Cancer Immunotherapy, Vol 165

  • ID: 4753622
  • Book
  • 300 Pages
  • Elsevier Science and Technology
1 of 4

Cancer Immunotherapy, Volume 165 in the Progress in Molecular Biology and Translational Science series provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy , Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy,

Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy.

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field
Note: Product cover images may vary from those shown
2 of 4

Chapters include: TNFR2 in cancer immunology and immunotherapy Xin Chen From the Hellstrom paradox towards cancer cure Ingegerd Hellstrom and Karl Erik Hellstrom CAR T-cell treatment of T-cell malignancy Martin Pule Immunotherapy of pancreatic cancer Jorg Kleeff Cancer stem cell immunology/immunotherapy Federica Cavallo Cytokine release syndrome Alexander Shimabukuro-Vornhagen Tumor Cell-Based Mechanisms of Resistance to Immune Attack Louis M. Weiner Mushroom compounds in cancer immunotherapy Peter Amwoga Ayeka

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Teplow, David B.
Professor Teplow is a member of the Department of Neurology, David Geffen School of Medicine at UCLA; Director, UCLA Biopolymer Laboratory; and a member of the faculties of the Molecular Biology Institute, Brain Research Institute, Chemistry-Biology Interface Training Program, and various neuroscience graduate programs. Professor Teplow received degrees in Biochemistry, and in Bacteriology & Immunology, from UC Berkeley; a Ph.D. from the University of Washington, Seattle; and postdoctoral training at the California Institute of Technology, Pasadena, CA. From 1991-2005, Professor Teplow was a member of the faculty of the Department of Neurology, Harvard Medical School, Boston. Professor Teplow has published >200 peer-reviewed articles, including ~150 original articles and ~50 reviews, book chapters, and commentaries. Professor Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology. He currently is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease. Professor Teplow is a member of numerous national and international scientific advisory and editorial boards.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4753622
Adroll
adroll